glp 1 for eating disorders disorder groups are sounding alarms about the rapid rollout of GLP-1 treatments, saying vulnerable people are being deliberately targeted by weight-loss marketing. The Australia and New Zealand Academy Eating GLP-1 access a problem for

When a man makes a diet change and feels better temporarily, placebo and regression to the mean can explain the perceived improvement

Patients with insulin resistance, metabolic dysfunction, or inadequate response to GLP-1 therapy may benefit more

Oral selenium (0.5 mg/kg body weight) combined with NAC (500 mg/kg body weight) demonstrated a greater protective effect than NAC alone when administered to rats within 1 hour of acetaminophen overdose (Yalin 2008)

This mimics normal physiology and avoids disrupting hormone feedback loops

Theyre happy with their weight loss but are frustrated that now theres a new problem that needs to be addressed